In short, the pharmaceutical industry expects to be ready for Y2K and is working with others in the supply chain to help maintain the uninterrupted flow of medicines. These companies are developing contingency plans to help ensure supply continuity. There is a clear indication from the survey that Y2K preparations are well underway in pharmaceutical companies and that most repair work is expected to be completed in early to mid-1999. Inc. Genentech, Inc Schering-Plough Corp. Genzyme Corporation SmithKline Beecham, p.l.c. The information provided below is intended to give pharmaceutical industry averages as of year-end 1998.
Actual results vary from company to company.
Identify the planned completion dates for each phase. Respond to the following questions regarding your systems with embedded chips.